Martin Fan
Stock Analyst at Wedbush
(1.69)
# 3,231
Out of 4,876 analysts
5
Total ratings
80%
Success rate
-0.16%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Martin Fan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACRS Aclaris Therapeutics | Initiates: Outperform | $8 | $1.47 | +444.22% | 1 | May 28, 2025 | |
| ORKA Oruka Therapeutics | Reiterates: Outperform | $40 | $11.08 | +261.01% | 1 | May 15, 2025 | |
| ANAB AnaptysBio | Reiterates: Outperform | $40 | $22.47 | +78.02% | 1 | May 1, 2025 | |
| ARTV Artiva Biotherapeutics | Reiterates: Outperform | $18 | $1.47 | +1,124.49% | 1 | Mar 25, 2025 | |
| ZBIO Zenas BioPharma | Initiates: Outperform | $35 | $9.58 | +265.34% | 1 | Mar 20, 2025 |
Aclaris Therapeutics
May 28, 2025
Initiates: Outperform
Price Target: $8
Current: $1.47
Upside: +444.22%
Oruka Therapeutics
May 15, 2025
Reiterates: Outperform
Price Target: $40
Current: $11.08
Upside: +261.01%
AnaptysBio
May 1, 2025
Reiterates: Outperform
Price Target: $40
Current: $22.47
Upside: +78.02%
Artiva Biotherapeutics
Mar 25, 2025
Reiterates: Outperform
Price Target: $18
Current: $1.47
Upside: +1,124.49%
Zenas BioPharma
Mar 20, 2025
Initiates: Outperform
Price Target: $35
Current: $9.58
Upside: +265.34%